Target intelligence / Profile preview

Acetate (as a bicarbonate precursor)

Molecular classification
Other (not an enzyme, receptor, transporter, or transcription factor; classified as a small molecule/metabolite or buffer ion)
01

Overview

The term "acetate as a bicarbonate precursor" refers to the clinical use of acetate-containing solutions in intravenous fluids to correct metabolic acidosis. Acetate, administered most often as the sodium salt, is efficiently converted in the body into bicarbonate, which acts as a buffer to neutralize excess acid and restore normal blood pH. Unlike lactate, acetate metabolism does not require hepatic function and is therefore effective even in liver-impaired patients. The process describes a *therapeutic physiological pathway* involving distributed small-molecule metabolism, not a discrete therapeutic target such as an enzyme or receptor. Acetate is also a central metabolic intermediate, involved in energy metabolism, lipid synthesis, and protein acetylation, but in this clinical setting its primary function is rapid conversion into bicarbonate to treat acid–base disorders.[1][3][5][7] This entry is **not** a canonical drug target and should not be used as such in structured biological or pharmacological databases.[1][4]

Other names
Acetate ionEthanoateSodium acetate (for the salt used in therapy)Bicarbonate precursor
02

Mechanism of action

Acetate, when administered intravenously, is rapidly metabolized (mainly in muscle and other tissues, independent of liver function) to produce bicarbonate ions, raising blood pH

03

Biological functions

Acid–base homeostasis (buffering metabolic acidosis)Precursor to bicarbonateSubstrate for acetyl-CoA synthesis and central metabolism
04

Disease associations

Acid–base disturbances (e.g., metabolic acidosis)Supportive fluid therapy in critical illness and renal failure
05

Safety considerations

Risk of overcorrection (metabolic alkalosis)Accumulation and toxicity if metabolic conversion is impaired (rare, but possible in severe multiorgan failure)Potential hemodynamic or metabolic complications with large-volume infusions (e.g., hypotension from rapid acetate metabolism)
06

Interacting drugs

Sodium acetate (as administered in IV fluids such as PlasmaLyte, Ringer's acetate)
07

Biomarkers

Blood pHSerum bicarbonate concentration (\(\mathrm{HCO}_3^-\\))Base excessBlood gas parameters

Beyond the preview

Go deeper on Acetate (as a bicarbonate precursor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetate (as a bicarbonate precursor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call